Polycythemia vera (PV) is a Philadelphia-negative chronic myeloproliferative neoplasm (MPN) characterized by the clonal expansion of an erythrocyte mass due to mutations in the JAK2 gene (V617F and exon 12) that cause hyperactivation of JAK-STAT signaling. Here, JAK2 is linked to acquired polycythemia vera.